Researchers have identified over 4,000 nanomedical clinical trials in progress now, highlighting rapid growth in the field and the need for a standardized lexicon to support clinical translation and collaboration.
Nanotechnology is the science of materials at the nanoscale, where matter behaves differently than it does at larger scales. The unique properties at this size have enabled the development of advanced tools for drug delivery, diagnostics, and therapeutics, tools that can significantly improve how diseases are detected and treated.
When applied to healthcare, nanotechnology has the potential to enhance treatment precision, reduce side effects, and increase therapeutic efficacy. With the help of specialized nanocarriers like liposomes, polymeric nanoparticles, or metallic nanoparticles, clinicians are better equipped to target specific tissues or cells.
However, for researchers to work collaboratively and for findings to be translatable across the globe, a standardized way to understand and unpick scientific work in nanomedicine is required. A recent review published in Nano Today hopes to kickstart a lexicon to do just that.
The Landscape of Nanomedical Trials
To assess the clinical integration of nanotechnology, the researchers analyzed over 500,000 studies from the Aggregate Analysis of ClinicalTrials.gov (AACT) database. Using a novel lexicon built with expert input and generative AI, they picked out 4,114 nanomedical trials spanning various conditions and therapeutic approaches.
Their standardizing lexicon was developed in multiple stages. Experts first created a foundation of terminology, which was expanded using AI-based tools and refined through iterative review. Researchers then used PostgreSQL and Python to extract data on each trial’s registration year, phase, intervention type, and associated medical condition.
This methodology enabled the team to classify a complex and evolving clinical landscape, offering insights into how and where nanotechnology is being applied across medicine.
Trends, Growth, and Ongoing Challenges
The analysis revealed a 38 % increase in nanomedical clinical trials in recent years, reflecting growing interest and investment in this space. Oncology remains the dominant focus, accounting for nearly a third of the trials. However, applications are broadening, with notable activity in infectious diseases, respiratory conditions, and neurological disorders.
There is also increasing diversification in the types of nanocarriers being explored, as researchers seek to improve drug delivery strategies and therapeutic outcomes. But despite this momentum, nanomedical trials still make up less than 1 % of all registered studies.
The field faces several challenges that may explain this discrepancy. Regulatory frameworks for nanomedicine are still maturing, production costs remain high, and designing clinical trials for such complex technologies can be difficult.
One of the study’s key recommendations is the adoption of a universally accepted nanomedical lexicon. Standardized terminology would improve data harmonization and facilitate interdisciplinary collaboration, as well as help streamline regulatory processes. These steps are critical if science is to bring nanomedicine into broader clinical use.
The majority of the trials identified in the review are still in early phases, indicating that much of the field remains in exploratory or proof-of-concept stages. Advancing more studies to late-phase trials will be essential to demonstrating long-term safety and efficacy.
Clinical Potential and Real-World Impact
The study reinforces nanomedicine’s practical value in areas such as targeted cancer treatment, vaccine development, and advanced diagnostics. The response to COVID-19 highlighted the adaptability of nanomedical platforms, with 505 trials focused on mRNA vaccine technologies. This suggests an expanding scope that now includes respiratory infections, HIV, and other pressing global health concerns.
Integrating AI into lexicon development may help to enhance the accuracy of trial classification and support clearer communication among researchers, clinicians, and regulatory agencies. As more multifunctional nanomedicines, such as theranostic agents that combine therapy and diagnostics, enter development, the potential for personalized treatment and real-time monitoring continues to grow.
Looking Ahead: Collaboration and Standardization
The review emphasizes the need for continued interdisciplinary collaboration for nanomedicine to flourish to its full potential. Establishing consistent terminology is not a technical exercise—it lays the foundation for improved communication, regulatory alignment, and clinical adoption.
Another key step is to address existing barriers like high production costs and trial design complexity. Future work in nanomedicine will focus on developing new tools, including integrating advanced machine learning techniques, to accelerate product development and optimization. Efforts are also being made to design multifunctional nanomedicines capable of adapting to individual patient needs and providing real-time therapeutic feedback.
As the field evolves, coordinated efforts between scientists, healthcare professionals, and regulatory bodies are essential for ensuring nanotechnology meaningfully enhances patient care.
Journal Reference
Gultepe, E., & et al. (2025). The landscape of nanomedical clinical trials. nanotoday, 66(102898). DOI: 10.1016/j.nantod.2025.102898, https://www.sciencedirect.com/science/article/pii/S1748013225002701
News
A Forgotten Molecule Could Revive Failing Antifungal Drugs and Save Millions of Lives
Scientists have uncovered a way to make existing antifungal drugs work again against deadly, drug-resistant fungi. Fungal infections claim millions of lives worldwide each year, and current medical treatments are failing to keep pace. [...]
Scientists Trap Thyme’s Healing Power in Tiny Capsules
A new micro-encapsulation breakthrough could turn thyme’s powerful health benefits into safer, smarter nanodoses. Thyme extract is often praised for its wide range of health benefits, giving it a reputation as a natural medicinal [...]
Scientists Develop Spray-On Powder That Instantly Seals Life-Threatening Wounds
KAIST scientists have created a fast-acting, stable powder hemostat that stops bleeding in one second and could significantly improve survival in combat and emergency medicine. Severe blood loss remains the primary cause of death from [...]
Oceans Are Struggling To Absorb Carbon As Microplastics Flood Their Waters
New research points to an unexpected way plastic pollution may be influencing Earth’s climate system. A recent study suggests that microscopic plastic pollution is reducing the ocean’s capacity to take in carbon dioxide, a [...]
Molecular Manufacturing: The Future of Nanomedicine – New book from Frank Boehm
This book explores the revolutionary potential of atomically precise manufacturing technologies to transform global healthcare, as well as practically every other sector across society. This forward-thinking volume examines how envisaged Factory@Home systems might enable the cost-effective [...]
New Book! NanoMedical Brain/Cloud Interface – Explorations and Implications
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence
A new book by Frank Boehm, NanoappsMedical Inc. Founder. This groundbreaking volume explores the vision of a Global Health Care Equivalency (GHCE) system powered by artificial intelligence and quantum computing technologies, operating on secure [...]
Miller School Researchers Pioneer Nanovanilloid-Based Brain Cooling for Traumatic Injury
A multidisciplinary team at the University of Miami Miller School of Medicine has developed a breakthrough nanodrug platform that may prove beneficial for rapid, targeted therapeutic hypothermia after traumatic brain injury (TBI). Their work, published in ACS [...]
COVID-19 still claims more than 100,000 US lives each year
Centers for Disease Control and Prevention researchers report national estimates of 43.6 million COVID-19-associated illnesses and 101,300 deaths in the US during October 2022 to September 2023, plus 33.0 million illnesses and 100,800 deaths [...]
Nanomedicine in 2026: Experts Predict the Year Ahead
Progress in nanomedicine is almost as fast as the science is small. Over the last year, we've seen an abundance of headlines covering medical R&D at the nanoscale: polymer-coated nanoparticles targeting ovarian cancer, Albumin recruiting nanoparticles for [...]
Lipid nanoparticles could unlock access for millions of autoimmune patients
Capstan Therapeutics scientists demonstrate that lipid nanoparticles can engineer CAR T cells within the body without laboratory cell manufacturing and ex vivo expansion. The method using targeted lipid nanoparticles (tLNPs) is designed to deliver [...]
The Brain’s Strange Way of Computing Could Explain Consciousness
Consciousness may emerge not from code, but from the way living brains physically compute. Discussions about consciousness often stall between two deeply rooted viewpoints. One is computational functionalism, which holds that cognition can be [...]
First breathing ‘lung-on-chip’ developed using genetically identical cells
Researchers at the Francis Crick Institute and AlveoliX have developed the first human lung-on-chip model using stem cells taken from only one person. These chips simulate breathing motions and lung disease in an individual, [...]
Cell Membranes May Act Like Tiny Power Generators
Living cells may generate electricity through the natural motion of their membranes. These fast electrical signals could play a role in how cells communicate and sense their surroundings. Scientists have proposed a new theoretical [...]
This Viral RNA Structure Could Lead to a Universal Antiviral Drug
Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for enteroviruses. A new study from the University of Maryland, Baltimore County (UMBC), published in Nature Communications, explains how enteroviruses begin reproducing [...]
New study suggests a way to rejuvenate the immune system
Stimulating the liver to produce some of the signals of the thymus can reverse age-related declines in T-cell populations and enhance response to vaccination. As people age, their immune system function declines. T cell [...]
